Related content

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

By Manenti L.   Paganoni P.   Floriani I.   Landoni F.   Torri V.   Buda A.   Taraboletti G.   Labianca R.   Belotti D.   Giavazzi R.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1948-1956

Elsevier

Access to resources Recommend Favorite

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

By Bjerre Christina  

Acta Oncologica, Vol. 52, Iss. 1, 2013-01 ,pp. : 82-90

Informa Healthcare

Access to resources Recommend Favorite

Longterm administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism

By              

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1499-1502

Spandidos Publications

Access to resources Recommend Favorite

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer

By Klintman Marie  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinases-1 Stimulates Gene Expression in MDA-MB-435 Human Breast Cancer Cells by Means of its Ability to Inhibit Metalloproteinases

By Porter Joseph   Sharma Shashi   Wilson Donna   Kappil Maya   Hart Ronald   Denhardt David  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 185-193

Springer Publishing Company

Access to resources Recommend Favorite